Table 4.
Parameters | RBZ+Laser Treated Group | BVZ+Laser Treated Group | p-value |
---|---|---|---|
HbA1C (%) | 7.97±2.92 | 8.14±2.77 | 0.7426 |
PBMC ROS (Geo mean of DCF/ 105 cells) | 100.7 ± 10.63 | 98.54 ± 16.28 | 0.5112 |
Serum AGE Conc. (µg/mL) | 3.146 ± 0.66 | 3.02 ± 0.803 | 0.3068 |
Serum MDA Conc. (nmol/mL) | 2.736 ± 0.4948 | 2.649 ± 0.6435 | 0.7293 |
Notes: Data were presented as mean ± SD. Not-normally distributed variables of two groups were compared by unpaired Mann Whitney U-test. The study showed no significant differences in HbA1c, PBMC ROS, AGE, and MDA between study groups. A value of p < 0.05 was considered statistically significant.
Abbreviations: PBMC, peripheral blood mononuclear cells; ROS, reactive oxygen species; DCF, Dichlorodihydrofluorescein Diacetate; AGE, advanced glycation end product; MDA, malondialdehyde.